Roberto Andini
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 20
- Infective Endocarditis Diagnosis and Management 9
- Pneumonia and Respiratory Infections 4
-
- Antimicrobial Resistance in Staphylococcus 8
- COVID-19 Clinical Research Studies 4
- Co-authors
- Emanuele Durante‐Mangoni (31 shared papers)Antonio Corcione (6 shared papers)Rosa Zampino (18 shared papers)Patrizia Murino (4 shared papers)Raffaele Zarrilli (3 shared papers)Riccardo Utili (8 shared papers)Lorenzo Bertolino (12 shared papers)Nicola Galdieri (3 shared papers)
- Journals
- International Journal of Antimicrobial Agents (3 papers)Infection (3 papers)Journal of Chemotherapy (3 papers)Journal of Clinical Medicine (2 papers)Antibiotics (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Roberto Andini
27 papers receiving 833 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 423
- Applied Microbiology and Biotechnology 160
- Pharmacology 289
- Infectious Diseases 281
- Endocrinology 65
Countries citing papers authored by Roberto Andini
This map shows the geographic impact of Roberto Andini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Andini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Andini more than expected).
Fields of papers citing papers by Roberto Andini
This network shows the impact of papers produced by Roberto Andini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Andini. The network helps show where Roberto Andini may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Andini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 311 | |
| 2 | 2020 | 109 | |
| 3 | 2021 | 73 | |
| 4 | 2021 | 55 | |
| 5 | 2015 | 49 | |
| 6 | 2021 | 47 | |
| 7 | 2020 | 26 | |
| 8 | 2016 | 23 | |
| 9 | 2022 | 20 | |
| 10 | 2020 | 19 | |
| 11 | 2023 | 15 | |
| 12 | 2014 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2015 | 13 | |
| 15 | 2015 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2017 | 5 |
About Roberto Andini
Roberto Andini is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Surgery and Pharmacology, having authored 31 papers that have together received 850 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Infective Endocarditis Diagnosis and Management (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (8 papers), COVID-19 Clinical Research Studies (4 papers), Transplantation: Methods and Outcomes (4 papers), Pneumonia and Respiratory Infections (4 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Molecular Medicine (423 citations), Applied Microbiology and Biotechnology (160 citations), Pharmacology (289 citations), Infectious Diseases (281 citations) and Endocrinology (65 citations). Roberto Andini has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Emanuele Durante‐Mangoni, Antonio Corcione, Rosa Zampino, Patrizia Murino, Raffaele Zarrilli, Riccardo Utili, Lorenzo Bertolino, Nicola Galdieri, Nicola Petrosillo and Giuseppe Signoriello. Their work appears in journals such as International Journal of Antimicrobial Agents, Infection, Journal of Chemotherapy, Journal of Clinical Medicine and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.